This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Biography of Inventor Xiang-ju Gu
Introduction: Xiang-ju Gu is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of protein kinase inhibitors.
Latest Patents: Xiang-ju Gu holds a patent for "Substituted pyrrolo[2,3-2]pyrimidines as protein kinase inhibitors." This invention provides a novel class of compounds and pharmaceutical compositions that can be used to treat or prevent diseases associated with abnormal kinase activity.
Career Highlights: Gu's work focuses on addressing disorders that involve abnormal activation of various kinases, including FAK, Abl, BCR-Abl, PDGF-R, c-Kit, NPM-ALK, Flt-3, JAK2, and c-Met. His innovative approach has the potential to impact the treatment of several serious health conditions.
Collaborations: Throughout his career, Xiang-ju Gu has collaborated with esteemed colleagues, including Ha-Soon Choi and Zhicheng Wang. These partnerships have enhanced the research and development of his inventions.
Conclusion: Xiang-ju Gu's contributions to the field of biotechnology and pharmaceuticals exemplify the impact of innovative thinking in addressing complex medical challenges. His work continues to inspire advancements in the treatment of diseases linked to kinase activity.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile